With the COVID-19 antivirals Paxlovid and Lagevrio now listed on the Pharmaceutical Benefits Scheme (PBS), GPs play a pivotal role in managing patients with COVID-19 infections. However, there are significant challenges in prescribing these medications.
Our expert panel included a respiratory specialist, a GP and a community pharmacist. They provided the latest evidence, hands-on experience and case studies on long COVID-19, and answered questions from the audience.